Unbearable for most Americans: NYT named the cost of Trump's treatment for COVID-19

A report from The New York Times said that the treatment of Donald Trump for coronavirus could cost the American health care system more than $ 100. The most important of the NYT report compiled by the Independent. According to the newspaper's calculations, the president's helicopter flights, multiple tests ...

'We won't even test on monkeys': why the United States refused the Russian vaccine against COVID-19

The United States reacted with suspicion to the Russian coronavirus vaccine and refused to cooperate, according to CNN. The Ministry of Health says that it did not offer such cooperation to the Americans. This and other news - in the BBC review. Do Americans need the Russian vaccine CNN reports ...

COVID-19, Heart Attack & Stroke: The Incredible Story of San Diego Recovery

After a three-month hospitalization with COVID-19, during which he suffered a heart attack and stroke, 61-year-old Hector Reinoso was discharged from La Jolla Hospital in San Diego on July 24, writes NBC San Diego. “Three long months in the hospital with sadness and uncertainty,” she said ...

'Such statements are inappropriate': in California, chiropractors promise to cure COVID-19

For most people, the coronavirus is a threat. But it appears to be a business opportunity for some chiropractors in the US, writes the LA Times. The California Council of Chiropractic Experts, the state regulator, told the newspaper columnist and author of this article that officials with ...

'Results are impressive': new COVID-19 drug cuts ventilator requirements by 80%

The preliminary results of a clinical trial of a new drug for the treatment of coronavirus showed that its use dramatically reduces the number of patients who require mechanical ventilation, while the time a patient spends in the hospital is reduced by a third, writes the BBC. The treatment developed by the British biotechnology company Synairgen ...

'Europe has not left': US bought world stock of remdesivir for treatment of COVID-19

The United States has purchased almost the entire world stock of remdesivir, an antiviral drug that can accelerate the recovery of patients infected with coronavirus, writes the New York Post. Head of the Department of Health and Human Services (HHS) Alex Hazard announced an agreement to provide a large amount of medicine for Gilead ...

How much will remdesivir treatment cost for Americans with COVID-19

The drug remdesivir for the treatment of COVID-19 will cost $ 3120 for a typical US patient with private insurance, Fox Business writes. Gilead Sciences Inc. published its pricing plans for remdesivir used to treat COVID-19, saying US hospitals will charge ...

Do not take for prevention: what you need to know about dexamethasone, which reduces mortality from COVID-19

There is a lot of enthusiasm among doctors in the US and Europe for an inexpensive drug that seems to help save the lives of people with severe COVID-19. What you need to know about dexamethasone, tells The Healthy. When the enthusiasm for hydroxychloroquine decreased due to the fact that ...

In the USA, they no longer treat COVID-19 with hydroxychloroquine: millions of doses are stuck in warehouses

After the US Food and Drug Administration (FDA) revoked the permission to treat coronavirus infection with hydroxychloroquine, the federal government found that 63 million unused doses remained in state warehouses, CNN writes. The government began to accumulate ...

'Save lives around the world': a cheap and popular drug reduces mortality from COVID-19

A cheap and widely available drug could help save the lives of patients seriously ill with coronavirus infection, the BBC reported. British experts say low-dose treatment with the steroid hormone drug dexamethasone is a major breakthrough in the fight against the deadly virus. The drug is part of the largest in ...

0 - 10 of 17